REQUEST A DEMO
Total
USD $0.00
Search more companies

Elan Pharma (India) Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Elan Pharma (India) Private Limited Profile Updated: May 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Elan Pharma (india) Private Limited is an unlisted company, incorporated on 04/06/1997. It has its registered office in the State of Maharashtra, India. Company's corporate identification number (CIN) is U24230MH1997PTC108497 and registration number is 108497. The company is a manufacturing, trade company, it is engaged in chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products, wholesale trading.

Legal Address
501-Raikar Chambers Govandi, Deonar,
Mumbai; Maharashtra; Postal Code: 400088

Contact Details: Purchase the Elan Pharma (India) Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Elan Pharma (India) Private Limited report to view the information.
Outstanding Shares:
Purchase the Elan Pharma (India) Private Limited report to view the information.
Registered Capital:
Purchase the Elan Pharma (India) Private Limited report to view the information.
Incorporation Date:
June 04, 1997
Key Executives
Purchase this report to view the information.
Whole Time Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
96.12%
Company Performance
Financial values in the chart are available after Elan Pharma (India) Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
19.25%
Total operating revenue
18.68%
Operating profit (EBIT)
17.67%
EBITDA
18.31%
Net Profit (Loss) for the Period
18.65%
Total assets
17.63%
Total equity
20.44%
Operating Profit Margin (ROS)
-0.53%
Net Profit Margin
-0.15%
Return on Equity (ROE)
-0.25%
Quick Ratio
-0.07%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?